The role of cyclooxygenase inhibitors in cancer prevention

WF Anderson, A Umar, JL Viner… - Current pharmaceutical …, 2002 - ingentaconnect.com
Carcinogenesis results from the long-term accumulation of genetic and epigenetic
aberrations at the molecular level, which are under constant selection pressure for growth …

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

RE Harris - Inflammopharmacology, 2009 - Springer
The existing epidemiologic literature was comprehensively reviewed to retrieve all
epidemiologic studies (case control and cohort studies) that examined exposure to …

Cyclooxygenase-2 and its role in colorectal cancer development

D Wendum, J Masliah, G Trugnan, JF Fléjou - Virchows Archiv, 2004 - Springer
Abstract Cyclooxygenase 2 (COX-2), also called prostaglandin endoperoxide synthase 2, is
involved in colorectal tumor development. This review deals with particular questions raised …

Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?

R Sanborn, CD Blanke - Seminars in oncology, 2005 - Elsevier
Currently, combination chemotherapy represents the standard of care treatment for patients
with metastatic colorectal cancer in the United States. Despite recent improvements with the …

Cyclooxygenase-2 and gastrointestinal cancer

JR Mann, RN DuBois - The Cancer Journal, 2004 - journals.lww.com
The cyclooxygenase (COX) enzymes (COX-1 and COX-2) are key enzymes of prostaglandin
(PG) biosynthesis. Nonselective non-steroidal anti-inflammatory drugs (NSAIDs) inhibit the …

COX-2: a target for colon cancer prevention

LJ Marnett, RN DuBois - Annual review of pharmacology and …, 2002 - annualreviews.org
▪ Abstract Disease prevention is one area that both public and governmental agencies
strongly support owing to its potential for an improved lifestyle and a reduction in health care …

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

K Subbaramaiah, AJ Dannenberg - Trends in pharmacological sciences, 2003 - cell.com
Abstract Cyclooxygenase2 (COX-2), an inducible prostaglandin G/H synthase, is
overexpressed in several human cancers. Here, the potential utility of selective COX-2 …

COX-2 and colorectal cancer

A Ferrandez, S Prescott, RW Burt - Current pharmaceutical …, 2003 - ingentaconnect.com
Metabolites of arachidonic acid participate in normal growth responses and in aberrant
cellular growth and proliferation, including carcinogenesis. The key step in the conversion of …

Coxibs: pharmacology, toxicity and efficacy in cancer clinical trials

LA Garcia Rodriguez, L Cea-Soriano… - … for Chemoprevention of …, 2013 - Springer
This chapter briefly summarizes the current knowledge about the role of nonsteroidal anti-
inflammatory drugs (NSAIDs), specially focusing on those selective for cyclooxygenase …

The cost‐effectiveness of aspirin versus cyclooxygenase‐2‐selective inhibitors for colorectal carcinoma chemoprevention in healthy individuals

C Hur, LS Simon, GS Gazelle - … International Journal of the …, 2004 - Wiley Online Library
BACKGROUND Aspirin therapy is accepted widely for secondary prevention in patients with
documented cardiovascular disease, but there is a growing trend among healthy individuals …